-
1
-
-
0033541491
-
Hepatocellular carcinoma
-
Schafer DE, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353:1253-7.
-
(1999)
Lancet
, vol.353
, pp. 1253-1257
-
-
Schafer, D.E.1
Sorrell, M.F.2
-
4
-
-
0029924107
-
Human tumor antigens recognized by T lymphocytes
-
Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183:725-9.
-
(1996)
J Exp Med
, vol.183
, pp. 725-729
-
-
Boon, T.1
Van Der Bruggen, P.2
-
5
-
-
0029992369
-
Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts
-
Toes RE, Kast WM, Blom RJ, Bakker SC, Offringa R, Melief CJ. Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts. Int J Cancer 1996; 66:686-91.
-
(1996)
Int J Cancer
, vol.66
, pp. 686-691
-
-
Toes, R.E.1
Kast, W.M.2
Blom, R.J.3
Bakker, S.C.4
Offringa, R.5
Melief, C.J.6
-
6
-
-
0030769148
-
Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes
-
Vierboom MPM, Nijman HM, Offringa R et al. Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes. J Exp Med 1997; 186:695-704.
-
(1997)
J Exp Med
, vol.186
, pp. 695-704
-
-
Vierboom, M.P.M.1
Nijman, H.M.2
Offringa, R.3
-
7
-
-
0141688283
-
Adoptive-cell transfer therapy for the treatment of patients with cancer
-
Dudley ME, Rosenberg SA. Adoptive-cell transfer therapy for the treatment of patients with cancer. Nature Rev Cancer 2003; 3:667-76.
-
(2003)
Nature Rev Cancer
, vol.3
, pp. 667-676
-
-
Dudley, M.E.1
Rosenberg, S.A.2
-
8
-
-
0030470404
-
Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
-
Murphy G, Tjoa B, Ragde H, Kenny G, Boynton A. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate 1996; 29:371-80.
-
(1996)
Prostate
, vol.29
, pp. 371-380
-
-
Murphy, G.1
Tjoa, B.2
Ragde, H.3
Kenny, G.4
Boynton, A.5
-
9
-
-
0031941423
-
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
-
Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998; 4:328-32.
-
(1998)
Nat Med
, vol.4
, pp. 328-332
-
-
Nestle, F.O.1
Alijagic, S.2
Gilliet, M.3
-
10
-
-
0031890206
-
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
-
Rosenberg SA, Yang JC, Schwartzentruber DJ et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998; 4:321-7.
-
(1998)
Nat Med
, vol.4
, pp. 321-327
-
-
Rosenberg, S.A.1
Yang, J.C.2
Schwartzentruber, D.J.3
-
11
-
-
0026322151
-
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
-
Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254:1643-7.
-
(1991)
Science
, vol.254
, pp. 1643-1647
-
-
Van Der Bruggen, P.1
Traversari, C.2
Chomez, P.3
Lurquin, C.4
De Plaen, E.5
Van Den Eynde, B.6
-
12
-
-
0026645959
-
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
-
Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992; 176:1453-7.
-
(1992)
J Exp Med
, vol.176
, pp. 1453-1457
-
-
Traversari, C.1
Van Der Bruggen, P.2
Luescher, I.F.3
Lurquin, C.4
Chomez, P.5
Van Pel, A.6
-
14
-
-
0034020427
-
Definition of tumor-associated antigens in hepatocellular carcinoma
-
Stenner LF, Luo G, Sahin U et al. Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2000; 9:285-90.
-
(2000)
Cancer Epidemiol Biomarkers Prev
, vol.9
, pp. 285-290
-
-
Stenner, L.F.1
Luo, G.2
Sahin, U.3
-
15
-
-
0037100267
-
Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies
-
Wang Y, Han KJ, Pang XW et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 2002; 169:1102-9.
-
(2002)
J Immunol
, vol.169
, pp. 1102-1109
-
-
Wang, Y.1
Han, K.J.2
Pang, X.W.3
-
16
-
-
0028206046
-
Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1
-
Wolfel T, Schneider J, Meyer Z et al. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1 Int J Cancer 1994; 57:413-8.
-
(1994)
Int J Cancer
, vol.57
, pp. 413-418
-
-
Wolfel, T.1
Schneider, J.2
Meyer, Z.3
-
17
-
-
0028304337
-
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
-
Cox AL, Skipper J, Chen Y et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994; 264:716.
-
(1994)
Science
, vol.264
, pp. 716
-
-
Cox, A.L.1
Skipper, J.2
Chen, Y.3
-
19
-
-
0041469728
-
HCA587 antigen expression in normal tissues and cancers: Correlation with tumor differentiation in hepatocellular carcinoma
-
Li B, Qian XP, Pang XW et al. HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma. Laboratory Invest 2003; 83:1185-92.
-
(2003)
Laboratory Invest
, vol.83
, pp. 1185-1192
-
-
Li, B.1
Qian, X.P.2
Pang, X.W.3
-
20
-
-
0033151591
-
The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
-
Vonderheide RH, Hahn WC, Schultze JL, Naddler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10:673-9.
-
(1999)
Immunity
, vol.10
, pp. 673-679
-
-
Vonderheide, R.H.1
Hahn, W.C.2
Schultze, J.L.3
Naddler, L.M.4
-
21
-
-
0030603987
-
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
-
Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Meth 1996; 196:137-51.
-
(1996)
J Immunol Meth
, vol.196
, pp. 137-151
-
-
Romani, N.1
Reider, D.2
Heuer, M.3
-
22
-
-
3342925367
-
The Granzyme B ELISPOT assay: An alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity
-
Shafer-Weaver KS, Sayers T, Strobl S et al. The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. J Translat Med 2003; 1:14.
-
(2003)
J Translat Med
, vol.1
, pp. 14
-
-
Shafer-Weaver, K.S.1
Sayers, T.2
Strobl, S.3
-
23
-
-
0029043976
-
Peptide binding to MHC class I molecules: Implications for antigenic peptide prediction
-
Parker KC, Shields M, DiBrino M et al. Peptide binding to MHC class I molecules: implications for antigenic peptide prediction. Immunol Res 1995; 14:34-57.
-
(1995)
Immunol Res
, vol.14
, pp. 34-57
-
-
Parker, K.C.1
Shields, M.2
DiBrino, M.3
-
24
-
-
0033388725
-
SYFPEITHI: Database for MHC ligands and peptide motifs
-
Rammensee HG, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50:213-9.
-
(1999)
Immunogenetics
, vol.50
, pp. 213-219
-
-
Rammensee, H.G.1
Bachmann, J.2
Emmerich, N.P.3
Bachor, O.A.4
Stevanovic, S.5
-
25
-
-
0026732781
-
Cationic lipids direct a viral glycoprotein into the class 1 major histocompatibility complex antigen-presentation pathway
-
Walker C, Selby M, Erickson A, Cataldo D, Valensi JP, Van Nest GV. Cationic lipids direct a viral glycoprotein into the class 1 major histocompatibility complex antigen-presentation pathway. Proc Natl Acad Sci USA 1992; 89:7915-8.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 7915-7918
-
-
Walker, C.1
Selby, M.2
Erickson, A.3
Cataldo, D.4
Valensi, J.P.5
Van Nest, G.V.6
-
26
-
-
0029912909
-
Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma
-
Kurokohchi K, Carrington M, Mann DL et al. Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology 1996; 23:1181-8.
-
(1996)
Hepatology
, vol.23
, pp. 1181-1188
-
-
Kurokohchi, K.1
Carrington, M.2
Mann, D.L.3
-
27
-
-
0003142849
-
Cancer/testis (CT) antigens - New link between gametogenesis and cancer
-
Old LJ. Cancer/testis (CT) antigens - new link between gametogenesis and cancer. Cancer Immunity 2001; 1:1-10.
-
(2001)
Cancer Immunity
, vol.1
, pp. 1-10
-
-
Old, L.J.1
-
28
-
-
0030890836
-
Cancer vaccines based on the identification of genes encoding cancer regression antigens
-
Rosenberg SA. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol Today 1997; 19:175-82.
-
(1997)
Immunol Today
, vol.19
, pp. 175-182
-
-
Rosenberg, S.A.1
-
29
-
-
0033811967
-
Design and evaluation of antigen-specific vaccination strategies against cancer
-
Offringa R, Van der Burg SH, Ossendorp F, Toes REM, Melief CJM. Design and evaluation of antigen-specific vaccination strategies against cancer. Current Opin Immunol 2000; 12:576-82.
-
(2000)
Current Opin Immunol
, vol.12
, pp. 576-582
-
-
Offringa, R.1
Van Der Burg, S.H.2
Ossendorp, F.3
Toes, R.E.M.4
Melief, C.J.M.5
-
30
-
-
0035721929
-
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: The role of cellular immunity in the etiopathogenesis of vitiligo
-
Palermo B, Campanelli R, Garbelli S et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2001; 117:326-32.
-
(2001)
J Invest Dermatol
, vol.117
, pp. 326-332
-
-
Palermo, B.1
Campanelli, R.2
Garbelli, S.3
-
32
-
-
0034039974
-
MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: Four new members of the MAGE family with tumor-specific expression
-
Lucas S, Plaen ED, Boon T. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression. Int J Cancer 2000; 87:55-60.
-
(2000)
Int J Cancer
, vol.87
, pp. 55-60
-
-
Lucas, S.1
Plaen, E.D.2
Boon, T.3
-
33
-
-
0033965361
-
CT10: A new CT antigen homologous to CT7 and the MAGE family, identified by representational difference analysis
-
Gure AO, Stockert E, Arden KC et al. CT10: a new CT antigen homologous to CT7 and the MAGE family, identified by representational difference analysis. Int J Cancer 2000; 85:726-32.
-
(2000)
Int J Cancer
, vol.85
, pp. 726-732
-
-
Gure, A.O.1
Stockert, E.2
Arden, K.C.3
-
34
-
-
0033405438
-
Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte- derived dendritic cells expands specific cytotoxic T cells and induceds regression of some metastases in advanced stage IV melanoma
-
Thurner B, Haendle I, Roder C et al. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte- derived dendritic cells expands specific cytotoxic T cells and induceds regression of some metastases in advanced stage IV melanoma. J Exp Med 1999; 190:1669-78.
-
(1999)
J Exp Med
, vol.190
, pp. 1669-1678
-
-
Thurner, B.1
Haendle, I.2
Roder, C.3
-
35
-
-
1642419534
-
Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2
-
Ma E, Germeau C, Vigneron N et al. Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2. Int J Cancer 2004; 109:698-702.
-
(2004)
Int J Cancer
, vol.109
, pp. 698-702
-
-
Ma, E.1
Germeau, C.2
Vigneron, N.3
-
36
-
-
0035500466
-
Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens
-
Schirle M, Weinschenk T, Stevanovic S. Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. J Immunol Meth 2001; 257:1-16.
-
(2001)
J Immunol Meth
, vol.257
, pp. 1-16
-
-
Schirle, M.1
Weinschenk, T.2
Stevanovic, S.3
-
37
-
-
0036718859
-
Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor α2 chain
-
Okano F, Storkus WJ, Chambers WH, Pollack IF, Okada H. Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor α2 chain. Clin Cancer Res 2002; 8:2851-5.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2851-2855
-
-
Okano, F.1
Storkus, W.J.2
Chambers, W.H.3
Pollack, I.F.4
Okada, H.5
-
38
-
-
0034306972
-
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
-
Dannull J, Diener PA, Prikler L et al. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer Res 2000; 60:5522-8.
-
(2000)
Cancer Res
, vol.60
, pp. 5522-5528
-
-
Dannull, J.1
Diener, P.A.2
Prikler, L.3
-
39
-
-
0036558080
-
+ T-cell epitope for the glycoprotein B homolog of human herpesvirus 8
-
+ T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood 2002; 99:3360-6.
-
(2002)
Blood
, vol.99
, pp. 3360-3366
-
-
Wang, Q.J.1
Huang, X.L.2
Rappocciolo, G.3
-
41
-
-
0027973079
-
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes
-
Sette A, Vitiello A, Reherman B et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994; 153:5586-92.
-
(1994)
J Immunol
, vol.153
, pp. 5586-5592
-
-
Sette, A.1
Vitiello, A.2
Reherman, B.3
-
42
-
-
0033179885
-
Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER
-
Paz P, Brouwenstijn N, Perry R, Shastri N. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. Immunity 1999; 11:241-7.
-
(1999)
Immunity
, vol.11
, pp. 241-247
-
-
Paz, P.1
Brouwenstijn, N.2
Perry, R.3
Shastri, N.4
-
43
-
-
0033046472
-
Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
-
Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999; 17:51-8.
-
(1999)
Annu Rev Immunol
, vol.17
, pp. 51-58
-
-
Yewdell, J.W.1
Bennink, J.R.2
-
44
-
-
17644398661
-
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
-
Shafer-Weaver KA, Sayers T, Kuhns DB et al. Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay. J Transl Med 2004; 20 (2):31-8.
-
(2004)
J Transl Med
, vol.20
, Issue.2
, pp. 31-38
-
-
Shafer-Weaver, K.A.1
Sayers, T.2
Kuhns, D.B.3
-
45
-
-
0032534598
-
HLA-independent heterogeneity of CD81 T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients
-
Reynolds SR, Celis E, Sette A et al. HLA-independent heterogeneity of CD81 T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. J Immunol 1998; 161:6970-6.
-
(1998)
J Immunol
, vol.161
, pp. 6970-6976
-
-
Reynolds, S.R.1
Celis, E.2
Sette, A.3
|